Gemcitabine and Rapamycin Exhibit Additive Effect against Osteosarcoma by Targeting Autophagy and Apoptosis.

Ando, Takashi; Ichikawa, Jiro; Fujimaki, Taro; Taniguchi, Naofumi; Takayama, Yoshihiro; Haro, Hirotaka

Ando, Takashi; Ichikawa, Jiro; Fujimaki, Taro; Taniguchi, Naofumi; Takayama, Yoshihiro; Haro, Hirotaka.

Afiliación

Ando T; Department of Orthopeadic Surgery, Yamanashi University School of Medicine, Yamanashi 409-3898, Japan.
Ichikawa J; Department of Orthopeadic Surgery, Yamanashi University School of Medicine, Yamanashi 409-3898, Japan.
Fujimaki T; Department of Orthopeadic Surgery, Yamanashi University School of Medicine, Yamanashi 409-3898, Japan.
Taniguchi N; Department of Orthopeadic Surgery, Yamanashi University School of Medicine, Yamanashi 409-3898, Japan.
Takayama Y; Department of Orthopeadic Surgery, Yamanashi University School of Medicine, Yamanashi 409-3898, Japan.
Haro H; Department of Orthopeadic Surgery, Yamanashi University School of Medicine, Yamanashi 409-3898, Japan.

Cancers (Basel) ; 12(11)2020 Oct 23.

Article en En | MEDLINE | ID: mdl-33114161

Palabras clave

angiogenesis; apoptosis; autophagy; gemcitabine; rapamycin

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Cancers (Basel) Año: 2020 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google